SEC Filing Summary: Griffin-American Healthcare REIT IV, Inc.
Business Context and Reporting Period
This Form 8-K was filed on April 7, 2020, by Griffin-American Healthcare REIT IV, Inc., a Maryland corporation and emerging growth company. The filing serves as a Regulation FD disclosure to distribute the company's Fourth Quarter and Year-End 2019 Investor Update Letter.
Financial Metrics
The provided filing text does not contain specific financial data. It references an attached Exhibit 99.1 (Investor Update Letter) which contains the Fourth Quarter and Year-End 2019 results, but the text of that letter is not included in the source input. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not available in this document.
Material Changes
The filing does not detail specific material changes in financial performance or operations within the text provided. It solely announces the release of the investor update letter.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, and specific risk factors are contained within the attached Exhibit 99.1, which is not part of the provided text. The filing explicitly states that the information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Key Facts for Investor Verification
- Verify the contents of Exhibit 99.1 (Fourth Quarter and Year-End 2019 Investor Update Letter) for actual financial performance data.
- Confirm the company's status as an emerging growth company and its election not to use the extended transition period for new accounting standards.
- Note that the information in this 8-K is for disclosure purposes only and is not subject to the liabilities of Section 18 of the Exchange Act.
- Identify Jeffrey T. Hanson as the Chief Executive Officer who authorized the filing.